ABSTRACT
INTRODUCTION

85
Breathing is essential for life. Central respiratory chemoreception is a mechanism 86 by which very small changes in tissue CO 2 /H + produce very large changes in breathing.
87
One region that is involved in central respiratory chemoreception is the retrotrapezoid 
METHODS
127
Animals
128
Animal use was in accordance with guidelines approved by the University of São 
Physiological experiments
134
Surgery and anesthesia
135
The surgical procedures and experimental protocols were similar to those described 
Statistics
236
Data were analyzed using one-way repeated measures ANOVA followed by
237
Newman Keul´s or Dunn's post hoc tests. All results are presented as means ± SEM.
238
Differences were considered significant when p < 0.05. 3% vs. Moxo + saline: 64 ± 3.8% of inhibition, p < 0.001, Figs. 4A-C). We also found that 294 yohimbine into the RTN was able to increase inspiratory time (1.7 ± 0.2 vs. saline: 0.6 ± 295 0.1 s, p < 0.001) (Fig. 4D ) without changing expiratory time (Fig. 4E) .
296
Despite the consistent inhibitory effect of NE on inspiratory activity, we found that decided to test effects of RTN injections of NE when both α 2 -and β-ARs were blocked.
314
Despite our evidence presented above that shows blockade of β-AR did not affect the α 2 -315 AR-mediated inhibitory response (Fig. 3C-E) , when both α 2 -and β-AR are blocked by co-316 application of yohimbine and propranolol (i.e., blocker cocktail) into the RTN, subsequent 317 injection of NE increased in Dia EMG amplitude and frequency and stimulated Abd EMG 318 activity (Fig. 6) . These results suggest β-ARs are functionally expressed in the RTN where 319 they serve to fine tune NE regulation of respiratory drive by influencing activity of α1-ARs. (Fig. 6) but not when just α 2 -ARs are blocked (Fig. 2) . Furthermore, in some of these pathologies treatment with a NE re-uptake blocker or NE 
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